✦ LIBER ✦

Phase II study of MLN8237 (alisertib), an investigational Aurora A kinase inhibitor, in patients with platinum-resistant or -refractory epithelial ovarian, fallopian tube, or primary peritoneal carcinoma

✍ Scribed by Ursula A. Matulonis; Sudarshan Sharma; Sharad Ghamande; Michael S. Gordon; Salvatore A. Del Prete; Isabelle Ray-Coquard; Elzbieta Kutarska; Hua Liu; Howard Fingert; Xiaofei Zhou; Hadi Danaee; Russell J. Schilder

Book ID: 118506697
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 408 KB
Volume: 127
Category: Article
ISSN: 0090-8258
DOI: 10.1016/j.ygyno.2012.06.040

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase 1/2 study of weekly paclitaxel wit

Phase 1/2 study of weekly paclitaxel with or without alisertib, an investigational aurora a kinase inhibitor: Phase 1 results in patients with recurrent epithelial ovarian, fallopian tube, primary peritoneal, or breast cancer

✍ G. Falchook; B. Goff; R. Kurzrock; H. Gray; L. Martin; R. Coleman; H. Xiao; X. Z 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 132 KB

A phase II trial of weekly docetaxel in

A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer

✍ Anna Berkenblit; Michael V. Seiden; Ursula A. Matulonis; Richard T. Penson; Caro 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 169 KB

A phase II evaluation of belinostat and

A phase II evaluation of belinostat and carboplatin in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal carcinoma: A gynecologic oncology group study

✍ Don S. Dizon; John A. Blessing; Richard T. Penson; Richard D. Drake; Joan L. Wal 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 197 KB

908 POSTER A Randomised phase II study o

908 POSTER A Randomised phase II study of phenoxodiol with platinum or taxane chemotherapy in chemoresistant epithelial ovarian cancer, fallopian tube cancer and primary peritoneal cancer

📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 145 KB

Randomised phase II study of docetaxel p

Randomised phase II study of docetaxel plus vandetanib versus docetaxel followed by vandetanib in patients with persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: SWOG S0904

✍ Coleman, Robert L.; Moon, James; Sood, Anil K.; Hu, Wei; Delmore, James E.; Bone 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 887 KB

A phase II, single-arm study of the anti

A phase II, single-arm study of the anti-α5β1 integrin antibody volociximab as monotherapy in patients with platinum-resistant advanced epithelial ovarian or primary peritoneal cancer

✍ Katherine M. Bell-McGuinn; Carolyn M. Matthews; Steffan N. Ho; Minal Barve; Lucy 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 586 KB